IBRX

US IPO Week Ahead: Billionaire doctor back with another IPO

An image of a pen on paper Credit: Shutterstock photo

The shortened holiday week ahead will see two deals come to market, raising just over $100 million combined. Coming off 15 pricings in May, the seasonally strong June should see similar or improved market activity.

NantHealth ( NH ) - Led by billionaire CEO Dr. Patrick Soon-Shiong, this healthcare IT company claims a $50 billion market opportunity for its SaaS-based data solutions. The company has a high cash burn ($36 million in MRQ) and an accumulated deficit of $324 million. Dr. Soon-Shiong is also the CEO of 2015 biotech IPO NantKwest ( NK ), down 70% since the offering. Insiders have indicated for 77% of the $91 million deal.

Sensus Healthcare ( SRTSU ) - The micro cap device maker is raising $11 million to expand its sales and marketing efforts of its non-surgical non-melanoma skin cancer treatment system. It is also paying a dividend to preferred shareholders.

Find out why institutional investors rely on Renaissance Capital's Pre-IPO Research for these IPOs.

Follow us on Twitter ( @IPOtweet ) for IPO news as it happens and register for our updates on the IPO market.

IPO Market Snapshot

The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is down 4% year-to-date, while the S&P 500 is up 3%. Renaissance Capital's IPO ETF ( IPO ) tracks the index, and top ETF holdings include Alibaba (BABA), Synchrony Financial (SYF) and Citizens Financial Group (CFG). The Renaissance International IPO Index is down 4% year-to-date, while ACWX is up 1%. Renaissance Capital's International IPO ETF ( IPOS ) tracks the index, and top ETF holdings include NN Group and Aena S.A. To find out if this is the best ETF for you, visit ourIPO Investing page .

The article US IPO Week Ahead: Billionaire doctor back with another IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.